{
    "Trade/Device Name(s)": [
        "ACURA PLUS Blood Glucose Monitoring System",
        "ACURA PLUS Blood Glucose Meter",
        "ACURA PLUS Blood Glucose Test Strips",
        "ACURA PLUS Control Solution"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "K103278",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083468",
        "K083468/A001"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "October 13, 2011",
    "Summary Letter Received Date": "October 17, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1345",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Lancing device"
    ],
    "Instrument(s)/Platform(s)": [
        "ACURA PLUS Meter (Model GM505RA)"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method"
    ],
    "Methodologies": [
        "Enzymatic glucose oxidase (Aspergillus sp.) measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Strips",
        "Control Solution",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for ACURA PLUS Blood Glucose Monitoring System measuring glucose in capillary whole blood using amperometric enzyme method",
    "Indications for Use Summary": "Intended for self-testing by people with diabetes at home for quantitative measurement of glucose in capillary whole blood from fingertip and alternate sites, as an aid in monitoring diabetes control; not for neonatal use or diabetes diagnosis/screening",
    "fda_folder": "Clinical Chemistry"
}